Real Estate

performance thin layer chromatography method for monitoring degradation products of

Description
Research and development professional, with over 40 years of experience in the development of Pharmaceutical dosage forms (human and veterinary), including novel drug delivery systems, natural products development, analytical research and BA/BE
Categories
Published
of 10
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  KOUR CHAND JINDAL Ph.D. Research and development professional, with over 40 years of experience in thedevelopment of Pharmaceutical dosage forms (human and veterinary), includingnovel drug delivery systems, natural products development, analytical researchand BA/BE studies. Successfully developed products (oral and ophthalmic) for NDA and ANDA filing. Developed many Drug Delivery technologies and filed 84patents and 41 publications. Has headed Pharma Research activities for over twenty seven years including Analytical Development, Packaging Developmentand Intellectual Property Rights and Corporate QA activities for a year. Hasserved both multinational and Indian Pharma majors and extensively involved indrug delivery research for collaborative projects. Has headed veterinaryformulations R&D of a MNC at Auckland for 4 years. PATENTS & PUBLICATIONS  No. of patents filed -84  No. of paper publications - 41  Book Chapter - 1 ACADEMIC ACTIVITIES (2003 -2008)  Member of the Board of Studies Faculty of Medicine, Punjabi University, Patiala, India  Member of Board of PG Studies in Pharmaceutical Sciences, Panjab University, Chandigarh  Member of Board of Studies in Pharmacy Panjab University, Chandigarh, India  Member of Board of Studies in Biotechnology & Engineering, Panjab University, Chandigarh  Member of Board of Studies and Research NIPER, Chandigarh GUIDE AND EXAMINER FOR Ph.D. STUDENTS  Birla Institute of Technology and Science, Pilani  Punjabi University, Patiala  Panjab University, Chandigarh  Manipal University, Manipal  University of Mumbai, Mumbai  NIPER, Chandigarh PUBLICATIONS 1.K. C. Jindal, R. S. Chaudhary, S. S. Gangwal, A. K. Singla and S. Khanna, Rifampicinstability : Effect of Buffers and pH. Die Pharmaceutiche Industries (Pharm Ind.) 57(5),420-422, 1995  2.K. C. Jindal, R. S. Chaudhary, A. K. Singla, S. S. Gangwal and S. Khanna, Highperformance thin layer chromatography method for monitoring degradation products of Rifampicin in drug excipient interaction studies. J. Chromatography A., 685, 195-199,1994.3.K. C. Jindal, R. S. Chaudhary, A. K. Singla, S. S. Gangwal and S. Khanna,Dissolution test method for rifampicin-isoniazid fixed dose formulations. J. Pharm.Biomed. Anal., 12(4), 493-497, 1994.4.Yateen Shah, Satish Joshi, K. C. Jindal and S. Khanna, High performance liquidchromatographic determination of Diclofenac Diethylammonium in gels. Drug Dev.Indust. Pharm., 20(7), 1303 – 1307, 19945.R. S. Chaudhary, S.S. Gangwal, V.K. Gupta, Y.N. Shah, K.C. Jindal, S.Khanna,Dissolution system for Nifedipine sustained release formulations. Drug Dev. Indust.Pharm., 19(15), 1939 – 1946, 1993. 6.Jindal, K. C., Effect of body and environment temperature changes on ADME [absorption, distribution, metabolism, and elimination] of drugs, Pharmacos, 20 27-34, 1975. 7.Jindal, K. C. Plant growth regulators. Pharmacos, 19 37-42, 1974. 8.Jaura, K. L.; Jindal, K. C.; Sharma, Krishan Kanta    Addition compounds of organotinhalides. I. Adducts of tri(n-propyl)tin chloride with amines. Indian Journal of Chemistry , 8(1), 91-3, 1970 9.Y. N. Shah, S.H. Joshi, K.C. Jindal, S. Khanna, Stability indicating HPLC method for Ribavirin and its Pharmaceutical Dosage Forms. Drug Dev. Indust. Pharm., 20(1), 85 –92, 1994.10.K. C. Jindal, R. S. Chaudhary, S. Khanna, Enteric Film Coating. Eastern Pharmacist,37 (433), 41 – 47, 199411.K. C. Jindal, R. S. Chaudhary, A. K. Singla, S. S. Gangwal and S. Khanna, Effect of Particle size on the bioavailability and dissolution rate of Rifampicin. Indian Drugs, 32(3),100 – 107, 1995. 12.R. S. Chaudhary, K. C. Jindal, and S. Khanna, Stability Testing of Pharmaceuticals,Eastern Pharmacist, 37(433), 65-68, 1994. 13.S. S. Gangwal, R. S. Chaudhary, K. C. Jindal, and S. Khanna, A comparativebioavailability of Ofloxacin from two tablet formulations. Indian Drugs, 31(2), 75-77,1994.14.K. C. Jindal and S. Khanna, Iron Deficiency and its implications. Eastern Pharmacist,Vol. XXXVI (421),33 – 37, 1993; And, Ind. J. Med. Sci. 47(6), 156 – 165, June 1993. 15.K. C. Jindal, M. K. Avachat, S. Khanna Spheronization Technique for Pharmaceuticals. Eastern Pharmacist, Vol. XXXVI (423), 31 – 35, 1993.  16.R. S. Chaudhary, S.S. Gangwal, M.K. Avachat, Y. N. Shah and K. C. Jindal,Determination of Diltiazem Hydrochloride in human serum by High Performance LiquidChromatography. J. Chromatogr. Biomed. Appl., 614, 261 – 266, 1993. 17.S.S. Gangwal, R.S. Chaudhary, K. C. Jindal, S. Khanna, A comparativePharmacokinetic Evaluation of two marketed Ciprofloxacin Tablet Formulations. IndianDrugs, 30(8), 381 – 383, 1993. 18.Satish Joshi, Yateen Shah, K. C. Jindal, S.Khanna, Simultaneous determination of Sulphadoxine & Pyrimethamine in dosage forms by HPLC. Eastern Pharmacist, Vol.XXXV (420), 129 – 130, 1992. 19.R. S. Chaudhary, S.S. Gangwal, K.C. Jindal, and S. Khanna, Reverse phase highperformance liquid chromatography of Ketorolac and its application to Bioequivalencestudies in human serum. J. chromatogr. Biomed. Appl., 614, 180 – 184, 1993. 20.S.S. Gangwal, R.S. Chaudhary, K.C. Jindal, S. Khanna, Determination of self generated alcohol from Herbal Oral liquid formulations by Gas Chromatography. EasternPharmacist, Vol. XXXV (420), 127 – 128, 1992. 21.Yateen Shah, Satish Joshi, M. K. Avachat and K. C. Jindal, HPLC determination of Terfenadine in Pharmaceutical Dosage forms. Indian drugs, Vol. 29(13), 620 – 622,1992. 22.K. C. Jindal, Bioavailability, Bioequivalence and Pharmacokinetic Studies. EasternPharmacist, XXXV (418), 37 – 41, 1992. 23.R. S. Chaudhary and K. C. Jindal, Progress of Biotechnology in Pharmaceuticals.Eastern Pharmacist, XXXV (414), 17 – 21, 1992.24.Yateen Shah, S. Khanna, K. C. Jindal and V. S. Dighe, Determination of Rifampicinand Isoniazid in pharmaceutical formulations by HPLC. Drug Dev. Indust. Pharm., Vol.18(4), 1589 – 1596, 1992.25.S. Joshi, Yateen Shah, K. C. Jindal and S. Khanna, Simultaneous determination of Diclofenac Sodium & Paracetamol in Tablets by HPLC. Eastern Pharmacist, Vol. XXXV(410), 113 – 114, 1992. 26.Yateen Shah, S. Khanna, K.C. Jindal and V.S. Dighe, High Performance LiquidChromatographic estimation of Domperidone in Dosage Forms. Indian J. Pharm. Sci.,52(2), 100 – 101, 1990. 27.Yateen Shah, S. Khanna, K.C. Jindal and V.S. Dighe, High Performance liquidchromatographic determination of Diltiazem Hydrochloride in tablets. Indian Drugs,27(6), 363 – 364, 1990.28.A.R.Katkurwar, R.S. Chaudhary, K.C. Jindal and S. Khanna, Determination of Diltiazem Hydrochloride in tablet formulations by Non-aqueous titrimetric method.Eastern Pharmacist, XXXIII (391), 141, 1990.  29.S. Andhari, S. Khanna, V.S. Dighe and K.C. Jindal, Effect of Alkalinity on the recoveryof Ethambutol Hydrochloride in tablets and raw material. Indian Drugs, 27(6), 365-366,199030.S. Andhari, S. Khanna, K. C. Jindal, Colorimetric determination of Ethambutol inTablets, Eastern Pharmacist, XXXII (384), 135-136, 1989. 31.S.K. Baveja and K. C. Jindal, Formulation of dry powder mixtures for reconstitution,Part I, Physical Assessment. Indian J. Pharm. Sci., 41(1), 20-24, 1979. 32.Bhutani H. Singh S. Jindal K.C. Drug-drug interaction studies on first-line anti-tuberculosis drugs, Pharmaceutical Development and Technology,10(4), 517-523, 200533.Mariappan T.T., Jindal K.C. and Singh S. Overestimation of rifampicin duringcolorimetric analysis of anti-tuberculosis FDC products containing isoniazid due toformation of isonicotinyl hydrazone. Journal of Pharmaceutical and Biomedical Analysis,36(4), 905-908, 200434.Mariappan T.T., Geetha T. Pandey R. Jindal K.C. and Singh S. Interference of isonicotinyl hydrazone in the microbiological analysis of rifampicin from anti-tuberculosisFDC products containing isoniazid, Journal of Pharmaceutical and Biomedical Analysis,36(3), 643-647, 200435.Bhutani H, Singh S, Vir S, Bhutani K.K., Kumar R, Chakraborti A.K. and Jindal K.C.,LC and LC-MS study of stress decomposition behaviour of Isoniazid and establishmentof validated stability- indicating assay method. Journal of Pharmaceutical andBiomedical Analysis, 43(4),1213-1220, 200736.Bhutani H, Singh S, Chakraborti A.K. and Jindal K.C., Mechanistic explanation to thecatalysis by Pyrazinamide and Ethambutol of reaction between Rifampicin and Isoniazidin anti-TB FDCs. Journal of Pharmaceutical and Biomedical Analysis, 39, 892-899, 200537.Bansal, Gulshan; Singh, Manjeet; Jindal, K. C.; Singh, Saranjit. Liquidchromatographic-ultraviolet-photodiode array detection and liquid chromatographic/massspectrometric studies to characterize degradation products of Glimepiride., Journal of Pharmaceutical and Biomedical Analysis, 48(3), 788-795, 200838.Bansal, Gulshan; Singh, Manjeet; Jindal, Kour Chand; Singh, Saranjit,   Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of Glibenclamide and development of a validatedstability-indicating method, Journal of AOAC International , 91(4), 709-719, 200839.Bansal, Gulshan; Singh, Manjeet; Jindal, K. C.; Singh, Saranjit   Characterization of Mass Ionizable Degradation Products of Gliclazide by LC/ESI-MS.   Journal of Liquid Chromatography & Related Technologies, 31(14), 2174-2193, 2008, 40.Bansal, Gulshan; Singh, Manjeet; Jindal, K. C.; Singh, Saranjit   LC and LC-MS Study on Establishment of Degradation Pathway of Glipizide under Forced Decomposition Conditions, Journal of Chromatographic Science, 46(6), 510-517, 2008,  41.Bansal, Gulshan; Singh, Manjeet; Jindal, Kour Chand. Forced degradation study on Gliclazide and application of validated stability-indicating HPLC-UV method in stability testing of Gliclazide tablets. Chromatographia , 66(9/10), 751-755, 2007, BOOK CHAPTER Parenteral Products in ‘ Pharmaceutical Product Development  ” Edited by N K Jain PATENTSSr.NoPatent/ PatentApplication/ FamilyTitleFiling dateMERIAL New Zealand1. PCT/US2018/039361 Dual active parasiticidal granule compositions, methods and uses thereof 25 June 2018 FDC Ltd. 2.1181/MUM/2010, PCT A novel Gastroretentive delivery of macrolide08 Apr 20103.437/MUM/2010, PCTStabilized fluconazole polymorph III formulation17 Feb 20104.1874/MUM/2009PCT A novel in-situ gel forming solution for ocular drug delivery13 Aug 20095.668/MUM/2009Solid pharmaceutical dosage forms23 Mar 20096. Patent No. IN271908  A novel oral controlled release dosage forms for water soluble drugs10 Mar 20167.1182/MUM/2009Gastroretentive delivery of minerals and nutraceuticals05 May 20098.1715/MUM/2009Solid oral pharmaceutical composition of Telmisartan27 Jul 20099.83/MUM/2010Solid oral pharmaceutical composition of Telmisartan11 Jan 201010.2526/MUM/2010Pharmaceutical composition of Telmisartan14 Sep 201011.293/MUM/2011Pharmaceutical composition of Telmisartan02 Feb 201112.1843/MUM/2009Cefixime formulation10 Aug 200913.1874/MUM/2009A novel in-situ gel forming solution for 13 Aug 2009
Search
Similar documents
View more...
Tags
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks
SAVE OUR EARTH

We need your sign to support Project to invent "SMART AND CONTROLLABLE REFLECTIVE BALLOONS" to cover the Sun and Save Our Earth.

More details...

Sign Now!

We are very appreciated for your Prompt Action!

x